Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon Resistance”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Not applicableTemporarily pausedNCT01471509
What this trial is testing

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Who this might be right for
Type 2 DiabetesMetabolic Syndrome
Minneapolis Veterans Affairs Medical Center 300
Not applicableStudy completedNCT03085511
What this trial is testing

High Quality Protein for Assisting With Weight Loss

Who this might be right for
Obesity
Texas Tech University 40
Large-scale testing (Phase 3)Study completedNCT00566189
What this trial is testing

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceObesity
University of Campinas, Brazil 36
Very early researchStudy completedNCT05093517
What this trial is testing

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Who this might be right for
Type 2 DiabetesGlucose Tolerance ImpairedInsulin Sensitivity
The University of Texas Health Science Center at San Antonio 4
Not applicableNot Yet RecruitingNCT07097987
What this trial is testing

Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion

Who this might be right for
Obesity
TCI Co., Ltd. 14
Testing effectiveness (Phase 2)WithdrawnNCT02846857
What this trial is testing

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal
Not applicableStudy completedNCT02105324
What this trial is testing

The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas

Who this might be right for
Type 1 Diabetes
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT05254418
What this trial is testing

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Diseases
Vanderbilt University Medical Center 7
Not applicableStudy completedNCT03680482
What this trial is testing

To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
University of Chile 17
Early research (Phase 1)Study completedNCT01951729
What this trial is testing

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Who this might be right for
Pre-diabetes
Washington University School of Medicine 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07300982
What this trial is testing

Studies of Insulin and Glucagon Action in the Liver

Who this might be right for
Diabetes (DM)
Duke University 40
Post-approval studies (Phase 4)Study completedNCT01761318
What this trial is testing

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Who this might be right for
Diabetes Mellitus Type 2Metabolic SyndromeCardiovascular Disease+2 more
Leiden University Medical Center 50
Not applicableUnknownNCT06154096
What this trial is testing

Liver Fat and Glucagon Resistance

Who this might be right for
Steatosis of Liver
Imperial College London 20
Early research (Phase 1)Study completedNCT01449019
What this trial is testing

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Ludwig-Maximilians - University of Munich 24
Testing effectiveness (Phase 2)Study completedNCT05193578
What this trial is testing

Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes

Who this might be right for
SchizophreniaPrediabetic State
Jan Frystyk 154
Not applicableStudy completedNCT01173978
What this trial is testing

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

Who this might be right for
Insulin ResistanceDeteriorated Glucose HomeostasisInactivity
Glostrup University Hospital, Copenhagen 10
Not applicableStudy completedNCT00811317
What this trial is testing

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Boston University Charles River Campus 11
Not applicableLooking for participantsNCT04629586
What this trial is testing

The T1D Exchange Registry

Who this might be right for
Diabetes Mellitus, Type 1DiabetesType 1 Diabetes+1 more
T1D Exchange, United States 50,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500586
What this trial is testing

The Effects of Glucagon on Hepatic Metabolism

Who this might be right for
ObesityType2diabetesNAFLD
Adrian Vella 21
Not applicableStudy completedNCT01917760
What this trial is testing

Pharmacokinetics Study of Gamma-aminobutyric Acid

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism Disorders+4 more
Huashan Hospital 12
Load More Results